NASDAQ:WCRX - Warner Chilcott Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Warner Chilcott Public Limited Company is a specialty pharmaceutical company. The Company is focused on the women's healthcare, gastroenterology, dermatology and urology segments of the branded pharmaceuticals market, primarily in North America. The Company's hormonal contraceptive product offerings include LOESTRIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), the branded product in the United States hormonal contraception market, and LO LOESTRIN FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), its new oral contraceptive product, launched in January 2011, that offers women the lowest dosage of estrogen of any oral contraceptive available in the United States market. In October 2013, Actavis Inc acquired the entire share capital of Warner Chilcott PLC.

Receive WCRX News and Ratings via Email

Sign-up to receive the latest news and ratings for WCRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
Current SymbolNASDAQ:WCRX
CUSIPG9436810
WebN/A
Phone+353-1-8972000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Warner Chilcott (NASDAQ:WCRX) Frequently Asked Questions

What is Warner Chilcott's stock symbol?

Warner Chilcott trades on the NASDAQ under the ticker symbol "WCRX."

Has Warner Chilcott been receiving favorable news coverage?

Press coverage about WCRX stock has trended neutral on Friday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Warner Chilcott earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news headlines about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days.

What other stocks do shareholders of Warner Chilcott own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Warner Chilcott investors own include Lionsgate (LGF), Check Point Software Technologies (CHKP), Concur Technologies (CNQR), Citrix Systems (CTXS), DISH Network (DISH), Fastenal (FAST), Sourcefire (FIRE), Five Below (FIVE), Fortinet (FTNT) and Hain Celestial Group (HAIN).

How do I buy shares of Warner Chilcott?

Shares of WCRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Warner Chilcott?

Warner Chilcott's mailing address is Grand Canal Square, DUBLIN,, Ireland. The specialty pharmaceutical company can be reached via phone at +353-1-8972000.


MarketBeat Community Rating for Warner Chilcott (NASDAQ WCRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  163 (Vote Outperform)
Underperform Votes:  141 (Vote Underperform)
Total Votes:  304
MarketBeat's community ratings are surveys of what our community members think about Warner Chilcott and other stocks. Vote "Outperform" if you believe WCRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WCRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Featured Article: Reverse Stock Split

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel